Immune response of submissive and aggressive mice under conditions of opioid receptor activation

M A Cheido1, G V Idova

  • 1Laboratory of Mechanisms of Neurochemical Modulation, Institute of Physiology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia. cheido@physiol.ru

Insights

Opioid receptor agonists selectively modulate immune responses in mice. Specific agonists prevented immune stimulation in aggressive mice, while others normalized immune function in mice exhibiting depression-like behavior.

Area of Science:

  • Neuroscience
  • Immunology
  • Behavioral Science

Background:

  • Behavioral states like aggression and depression can alter immune system function.
  • Opioid receptors play a role in both the central nervous system and immune regulation.

Purpose of the Study:

  • To investigate the effects of selective opioid receptor agonists on immune responses in mice with different behavioral profiles.
  • To determine if specific opioid receptor modulation can normalize altered immune function.

Main Methods:

  • Experiments utilized a paired sensory contact model in mice.
  • Selective delta-2 (δ(2)) and kappa (κ)-opioid receptor agonists (DSLET and rimorphin) were administered at 100 microg/kg.
  • Mu (μ)-opioid receptor stimulation was also tested in mice with depression-like behavior.

Main Results:

  • Selective δ(2)- and κ-opioid receptor agonists prevented immune response stimulation in aggressive mice.
  • μ-opioid receptor stimulation normalized, but did not suppress, immune response in mice with depression-like behavior.
  • These findings suggest a differential effect of opioid receptor subtypes on immune modulation.

Conclusions:

  • Selective modulation of specific opioid receptor types can normalize immune function.
  • Opioid receptor activity is intricately linked to the development of specific behavioral types and their associated immune changes.